Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review

Chi Hung Liu; Li Chung Chiu; Chih Chun Lee; Tien Ming Chan

doi:10.3389/fimmu.2023.1240089

Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review

Chi Hung Liu
, Li Chung Chiu
, Chih Chun Lee
, Tien Ming Chan^*

^*Corresponding author for this work

Chang Gung Memorial Hospital
Chang Gung University

Research output: Contribution to journal › Journal Article › peer-review

9 Scopus citations

Abstract

Autoimmune encephalitis is a rare but critical complication of COVID-19. The management of COVID-19-associated autoimmune encephalitis includes the use of steroids, intravenous immunoglobulin (IVIG), plasmapheresis, and monoclonal antibody therapy. This study presented a patient with critical COVID-19 autoimmune encephalitis who rapidly recovered after the initiation of corticosteroids and IVIG therapy. This study reviewed the current literature on the pathophysiological mechanisms, diagnosis, and management of COVID-19-associated autoimmune encephalitis.

Original language	English
Article number	1240089
Journal	Frontiers in Immunology
Volume	14
DOIs	https://doi.org/10.3389/fimmu.2023.1240089
State	Published - 2023
Externally published	Yes

Bibliographical note

Publisher Copyright:
Copyright © 2023 Liu, Chiu, Lee and Chan.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

COVID-19
IVIG (intravenous immunoglobulin) administration
autoimmune encephalitis
diagnosis
high-dose steroid therapy

Access to Document

10.3389/fimmu.2023.1240089

Cite this

@article{12ed98a0a9a4440c9b3a73cb04135982,

title = "Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review",

abstract = "Autoimmune encephalitis is a rare but critical complication of COVID-19. The management of COVID-19-associated autoimmune encephalitis includes the use of steroids, intravenous immunoglobulin (IVIG), plasmapheresis, and monoclonal antibody therapy. This study presented a patient with critical COVID-19 autoimmune encephalitis who rapidly recovered after the initiation of corticosteroids and IVIG therapy. This study reviewed the current literature on the pathophysiological mechanisms, diagnosis, and management of COVID-19-associated autoimmune encephalitis.",

keywords = "COVID-19, IVIG (intravenous immunoglobulin) administration, autoimmune encephalitis, diagnosis, high-dose steroid therapy",

author = "Liu, \{Chi Hung\} and Chiu, \{Li Chung\} and Lee, \{Chih Chun\} and Chan, \{Tien Ming\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2023 Liu, Chiu, Lee and Chan.",

year = "2023",

doi = "10.3389/fimmu.2023.1240089",

language = "英语",

volume = "14",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Case Report

T2 - High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review

AU - Liu, Chi Hung

AU - Chiu, Li Chung

AU - Lee, Chih Chun

AU - Chan, Tien Ming

PY - 2023

Y1 - 2023

N2 - Autoimmune encephalitis is a rare but critical complication of COVID-19. The management of COVID-19-associated autoimmune encephalitis includes the use of steroids, intravenous immunoglobulin (IVIG), plasmapheresis, and monoclonal antibody therapy. This study presented a patient with critical COVID-19 autoimmune encephalitis who rapidly recovered after the initiation of corticosteroids and IVIG therapy. This study reviewed the current literature on the pathophysiological mechanisms, diagnosis, and management of COVID-19-associated autoimmune encephalitis.

AB - Autoimmune encephalitis is a rare but critical complication of COVID-19. The management of COVID-19-associated autoimmune encephalitis includes the use of steroids, intravenous immunoglobulin (IVIG), plasmapheresis, and monoclonal antibody therapy. This study presented a patient with critical COVID-19 autoimmune encephalitis who rapidly recovered after the initiation of corticosteroids and IVIG therapy. This study reviewed the current literature on the pathophysiological mechanisms, diagnosis, and management of COVID-19-associated autoimmune encephalitis.

KW - COVID-19

KW - IVIG (intravenous immunoglobulin) administration

KW - autoimmune encephalitis

KW - diagnosis

KW - high-dose steroid therapy

UR - https://www.scopus.com/pages/publications/85173774066

U2 - 10.3389/fimmu.2023.1240089

DO - 10.3389/fimmu.2023.1240089

M3 - 文章

C2 - 37809102

AN - SCOPUS:85173774066

SN - 1664-3224

VL - 14

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1240089

ER -

Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this